Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients

Figure 7

(a) Forest plot of the risk of the main adverse events in DD study. (b) Forest plot of the risk of the main adverse events in NDD study. (c) Funnel plot of the risk of the main adverse events in DD study. (d) Funnel plot of the risk of the main adverse events in NDD study.

(a)

(b)

(c)

(d)